These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 36005828)

  • 1. Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions.
    Gattuso G; Crimi S; Lavoro A; Rizzo R; Musumarra G; Gallo S; Facciponte F; Paratore S; Russo A; Bordonaro R; Isola G; Bianchi A; Libra M; Falzone L
    Noncoding RNA; 2022 Aug; 8(4):. PubMed ID: 36005828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid biopsy in ovarian cancer: the potential of circulating miRNAs and exosomes.
    Giannopoulou L; Zavridou M; Kasimir-Bauer S; Lianidou ES
    Transl Res; 2019 Mar; 205():77-91. PubMed ID: 30391474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic liquid biopsy components as predictive and prognostic biomarkers in colorectal cancer.
    Raza A; Khan AQ; Inchakalody VP; Mestiri S; Yoosuf ZSKM; Bedhiafi T; El-Ella DMA; Taib N; Hydrose S; Akbar S; Fernandes Q; Al-Zaidan L; Krishnankutty R; Merhi M; Uddin S; Dermime S
    J Exp Clin Cancer Res; 2022 Mar; 41(1):99. PubMed ID: 35292091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced liquid biopsy technologies for circulating biomarker detection.
    Soda N; Rehm BHA; Sonar P; Nguyen NT; Shiddiky MJA
    J Mater Chem B; 2019 Nov; 7(43):6670-6704. PubMed ID: 31646316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid biopsy in ovarian cancer.
    Giannopoulou L; Lianidou ES
    Adv Clin Chem; 2020; 97():13-71. PubMed ID: 32448432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic Landscape of Liquid Biopsy for Hepatocellular Carcinoma Personalized Medicine.
    Moldogazieva NT; Zavadskiy SP; Terentiev AA
    Cancer Genomics Proteomics; 2021; 18(3 Suppl):369-383. PubMed ID: 33994362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liquid biopsy in head and neck squamous cell carcinoma: circulating tumor cells, circulating tumor DNA, and exosomes.
    Yang WY; Feng LF; Meng X; Chen R; Xu WH; Hou J; Xu T; Zhang L
    Expert Rev Mol Diagn; 2020 Dec; 20(12):1213-1227. PubMed ID: 33232189
    [No Abstract]   [Full Text] [Related]  

  • 8. Circulating tumor DNA as an emerging liquid biopsy biomarker for early diagnosis and therapeutic monitoring in hepatocellular carcinoma.
    Wu X; Li J; Gassa A; Buchner D; Alakus H; Dong Q; Ren N; Liu M; Odenthal M; Stippel D; Bruns C; Zhao Y; Wahba R
    Int J Biol Sci; 2020; 16(9):1551-1562. PubMed ID: 32226301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liquid Biopsy in Oral Cancer.
    Lousada-Fernandez F; Rapado-Gonzalez O; Lopez-Cedrun JL; Lopez-Lopez R; Muinelo-Romay L; Suarez-Cunqueiro MM
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Salivary Biomarkers for Oral Squamous Cell Carcinoma Diagnosis and Follow-Up: Current Status and Perspectives.
    Cristaldi M; Mauceri R; Di Fede O; Giuliana G; Campisi G; Panzarella V
    Front Physiol; 2019; 10():1476. PubMed ID: 31920689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating microRNAs as Promising Biomarkers in Colorectal Cancer.
    Rapado-González Ó; Álvarez-Castro A; López-López R; Iglesias-Canle J; Suárez-Cunqueiro MM; Muinelo-Romay L
    Cancers (Basel); 2019 Jun; 11(7):. PubMed ID: 31252648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liquid biopsy at the frontier of detection, prognosis and progression monitoring in colorectal cancer.
    Zhou H; Zhu L; Song J; Wang G; Li P; Li W; Luo P; Sun X; Wu J; Liu Y; Zhu S; Zhang Y
    Mol Cancer; 2022 Mar; 21(1):86. PubMed ID: 35337361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review.
    Yang J; Xu R; Wang C; Qiu J; Ren B; You L
    Cancer Commun (Lond); 2021 Dec; 41(12):1257-1274. PubMed ID: 34331845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Updates on liquid biopsy: current trends and future perspectives for clinical application in solid tumors.
    Pinzani P; D'Argenio V; Del Re M; Pellegrini C; Cucchiara F; Salvianti F; Galbiati S
    Clin Chem Lab Med; 2021 Jun; 59(7):1181-1200. PubMed ID: 33544478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential of liquid biopsy in the management of cancer patients.
    Markou A; Tzanikou E; Lianidou E
    Semin Cancer Biol; 2022 Sep; 84():69-79. PubMed ID: 35331850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid biopsy: Exosomal microRNAs as novel diagnostic and prognostic biomarkers in cancer.
    Preethi KA; Selvakumar SC; Ross K; Jayaraman S; Tusubira D; Sekar D
    Mol Cancer; 2022 Feb; 21(1):54. PubMed ID: 35172817
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liquid Biopsy: A New Translational Diagnostic and Monitoring Tool for Musculoskeletal Tumors.
    Hadjimichael AC; Pergaris A; Kaspiris A; Foukas AF; Theocharis SE
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-Free microRNAs as Potential Oral Cancer Biomarkers: From Diagnosis to Therapy.
    Rapado-González Ó; López-López R; López-Cedrún JL; Triana-Martínez G; Muinelo-Romay L; Suárez-Cunqueiro MM
    Cells; 2019 Dec; 8(12):. PubMed ID: 31861130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid biopsy: a step forward towards precision medicine in urologic malignancies.
    Di Meo A; Bartlett J; Cheng Y; Pasic MD; Yousef GM
    Mol Cancer; 2017 Apr; 16(1):80. PubMed ID: 28410618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liquid Biomarkers for Improved Diagnosis and Classification of CNS Tumors.
    Bunda S; Zuccato JA; Voisin MR; Wang JZ; Nassiri F; Patil V; Mansouri S; Zadeh G
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.